Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant NY-ESO-1 protein mixed with glucopyranosyl lipid A |
---|---|
Date Designated: | 01/06/2016 |
Orphan Designation: | Treatment of soft tissue sarcoma. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 08/13/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Immune Design Corp. 1616 Eastlake Ave. E Suite 310 Seattle, Washington 98102 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-